Impact of a Communication Strategy in the Prevention of Depressive Symptoms in Patients with Covid-19
NCT ID: NCT05035563
Last Updated: 2025-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
350 participants
INTERVENTIONAL
2021-06-01
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Evaluating the rate of depressive symptoms at 3 months after discharge from the ICU, with a) Hospital Anxiety and Depression, b) Posttraumatic Stress Disorder Checklist (S)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acceptability and Feasibility of an In-person 8-week Mindfulness-Based Cognitive Therapy Program Among Undergraduates
NCT06757842
Psychosocial Group Interventions for Depression
NCT02149381
Implementation of a Psychological Online Intervention for Low to Moderate Depression in Primary Health Care
NCT05294614
Technology-assisted Collaborative Care Program for Depressed Patients With Chronic Disease at Primary Care
NCT04613076
Brief Telephone Psychological Intervention for Depressive Symptoms in Caregivers
NCT02292394
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study is implementation in 10 Chilean hospitals, admitting 350 patients.
Pre-intervention: The practices of each ICU will be maintained, until the moment that according to randomization corresponds the beginning of the intervention, in each center.
Post-intervention: EICS to facilitate communication between the family, patient and health team, through written material, via the web (tablet and webmaster) and by telephone.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
Post-intervention: Integral and early strategy to facilitate communication between the family, patient and health team. For this it will be implemented written material, via the web (tablet and webmaster) and by telephone.
It also includes strategies to support health teams, weekly multidisciplinary virtual meetings with the family, ICU diaries for family members.
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Traditional communication management (Pre-intervention)
Traditional communication practices are maintained, which consists of reporting the patient's medical conditions or specific requirements of the case, between the health team and the family.
According to the social and administrative conditions of each centers, medical telephone information is provided on the conditions of the patients.
No interventions assigned to this group
Early and integral communication strategy (EICS) (Post-intervention)
EICS that includes a bundle of various strategies that allow to favor communication and contact between family members, patients and health team.
That considers the delivery of: (1) Receive timely and understandable information; (2) Receive visits, companionship, and spiritual assistance
Intervention. Early and integral communication strategy (EICS)
This intervention will be implemented in patients since they are hospitalized in the ICU where is expected:
* Facilitate contact and communication between patients, families and the health team.
* Respond to the communication needs of family members.
* Reduce equipment overload and facilitate communication with families and patients, providing tools and timely support.
* Build a positive and trusting relationship of relatives and patients with health teams.
The intervention considers the following actions:
1. \- Training in communication to the health team
2. \- Written material
3. \- Family website
4. \- Standardized and daily telephone information
5. \- Health Team Support Strategy
6. \- Weekly multidisciplinary virtual meeting with the family
7. \- ICU diaries for family members
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention. Early and integral communication strategy (EICS)
This intervention will be implemented in patients since they are hospitalized in the ICU where is expected:
* Facilitate contact and communication between patients, families and the health team.
* Respond to the communication needs of family members.
* Reduce equipment overload and facilitate communication with families and patients, providing tools and timely support.
* Build a positive and trusting relationship of relatives and patients with health teams.
The intervention considers the following actions:
1. \- Training in communication to the health team
2. \- Written material
3. \- Family website
4. \- Standardized and daily telephone information
5. \- Health Team Support Strategy
6. \- Weekly multidisciplinary virtual meeting with the family
7. \- ICU diaries for family members
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to the ICU
* Requiring Mechanical Ventilation\> 12 hrs due to COVID-19
Exclusion Criteria
* Patients with communication limitations (they do not speak Spanish) are excluded.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chile
OTHER
Universidad de La Frontera
OTHER
Pontificia Universidad Catolica de Chile
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leyla Alegria
Role: PRINCIPAL_INVESTIGATOR
Pontificia Universidad Catolica de Chile
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pontificia Universidad Católica de Chile - Medicina
Santiago, Santiago Metropolitan, Chile
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID0921
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.